Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs Alone
Sponsor: AstraZeneca
Summary
The purpose of this study is to determine whether treatment with AZD9550 when given in combination with AZD6234 as once weekly subcutaneous (SC) injections is superior to placebo or either agent administered as monotherapy for weight loss in participants living with obesity or overweight with at least one weight-related co-morbidity.
Official title: A Phase IIb Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Co-administration of AZD9550 and AZD6234 in Participants Living With Obesity or Overweight With Co-morbidity (ASCEND)
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
377
Start Date
2025-02-18
Completion Date
2026-05-25
Last Updated
2026-02-02
Healthy Volunteers
No
Conditions
Interventions
AZD9550
IMP injected subcutaneous, once weekly. Unit dose strength as per CSP
AZD6234
IMP injected subcutaneous, once weekly. Unit dose strength as per CSP.
Placebo comparator
Placebo matching IMP dose injected subcutaneously, once weekly.
Locations (53)
Research Site
Dothan, Alabama, United States
Research Site
Vestavia Hills, Alabama, United States
Research Site
Cerritos, California, United States
Research Site
Escondido, California, United States
Research Site
Huntington Park, California, United States
Research Site
Lincoln, California, United States
Research Site
Sacramento, California, United States
Research Site
Waterbury, Connecticut, United States
Research Site
Palm Harbor, Florida, United States
Research Site
Decatur, Georgia, United States
Research Site
Stockbridge, Georgia, United States
Research Site
Champaign, Illinois, United States
Research Site
South Bend, Indiana, United States
Research Site
Valparaiso, Indiana, United States
Research Site
Sioux City, Iowa, United States
Research Site
Southfield, Michigan, United States
Research Site
Missoula, Montana, United States
Research Site
Omaha, Nebraska, United States
Research Site
Albuquerque, New Mexico, United States
Research Site
Fargo, North Dakota, United States
Research Site
Cincinnati, Ohio, United States
Research Site
Columbus, Ohio, United States
Research Site
Tulsa, Oklahoma, United States
Research Site
Medford, Oregon, United States
Research Site
Kingsport, Tennessee, United States
Research Site
Brownsville, Texas, United States
Research Site
Houston, Texas, United States
Research Site
Arlington, Virginia, United States
Research Site
Renton, Washington, United States
Research Site
Maroochydore, Australia
Research Site
Maroubra, Australia
Research Site
Norwood, Australia
Research Site
St Albans, Australia
Research Site
St Leonards, Australia
Research Site
Calgary, Alberta, Canada
Research Site
Surrey, British Columbia, Canada
Research Site
Guelph, Ontario, Canada
Research Site
Hamilton, Ontario, Canada
Research Site
Hamilton, Ontario, Canada
Research Site
Sarnia, Ontario, Canada
Research Site
Stouffville, Ontario, Canada
Research Site
Montreal, Quebec, Canada
Research Site
Berlin, Germany
Research Site
Essen, Germany
Research Site
Falkensee, Germany
Research Site
Hamburg, Germany
Research Site
Münster, Germany
Research Site
Oldenburg, Germany
Research Site
Chūōku, Japan
Research Site
Chūōku, Japan
Research Site
Fukuoka, Japan
Research Site
Shinjuku-ku, Japan
Research Site
Suita-shi, Japan